Concentrix Corporation is issuing $600 million of 6.500% senior unsecured notes maturing March 1, 2029. The notes pay semi-annual interest starting September 1, 2026 and the coupon can step up by up to 2.000 percentage points if credit ratings are downgraded.
Concentrix expects net proceeds of about $595.2 million, to be used with other funds to redeem or repay part or all of its outstanding $800 million 6.650% senior notes due August 2, 2026. The new notes are redeemable at Concentrix’s option, include a change-of-control repurchase feature at 101% of principal, are not guaranteed by subsidiaries, and will not be listed on any securities exchange.
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended Schedule 13G reporting beneficial ownership of 2,950,287 shares of Concentrix Corp common stock, representing 4.74% of the class as of 12/31/2025. Both entities report no sole voting or dispositive power over the shares, but shared voting and shared dispositive power for the full amount. The firms state the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Concentrix.
Concentrix Corporation plans a new unsecured senior notes offering to raise cash in the bond market. The notes will pay fixed interest semi-annually and mature on a specified future date, with the coupon step‑up feature tied to ratings from Moody’s, S&P and Fitch, capped at an extra 2.000 percentage points.
Concentrix expects to use the net proceeds, together with other funds, to redeem or repay all or part of its 6.650% senior notes due August 2, 2026, of which $800 million is outstanding, and to pay related fees. The new notes rank equally with the company’s other unsecured senior debt and are structurally subordinated to subsidiary obligations, including about $537 million of subsidiary debt within a broader $4.6 billion total debt load as of November 30, 2025. The company does not plan to list the notes, so liquidity will depend on dealer market‑making.
Concentrix Corp executive Cormac J. Twomey reported a routine share transaction. On 02/01/2026, he disposed of 1,439 shares of Concentrix common stock in a transaction coded "F" at a price of $37.35 per share. Following this activity, he directly beneficially owned 56,995 common shares as EVP, Global Ops & Delivery.
Concentrix Corp President and CEO Christopher A. Caldwell, who also serves as a director, reported a disposition of company common stock. On 02/01/2026, he disposed of 5,693 shares at a price of $37.35 per share, in a transaction coded "F."
Following this transaction, Caldwell directly beneficially owned 356,382 shares of Concentrix common stock. The filing is made as a single‑person Form 4, reflecting his status as both an officer and director of the company.
Concentrix Corp's Chief Financial Officer reports a small share disposition. CFO Andre S. Valentine filed a Form 4 showing the disposition of 864 shares of Concentrix common stock on February 1, 2026, at a price of $37.35 per share under transaction code "F," typically used for tax withholding on equity awards.
After this transaction, Valentine directly beneficially owns 86,566 shares of Concentrix common stock. The filing reflects routine insider equity administration rather than a large open-market trade.
Concentrix Corp executive Gibson Craig, EVP of Global Sales and Account Management, reported a disposition of common stock in a Form 4 filing. On February 1, 2026, Craig disposed of 799 shares of Concentrix common stock at $37.35 per share. After this transaction, he directly owned 53,599 shares of Concentrix common stock.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported a disposition of Concentrix common stock. On 02/01/2026, 563 shares were disposed of at a price of $37.35 per share. Following this transaction, she directly beneficially owned 31,030 shares of Concentrix common stock.
Concentrix Corp President and CEO Christopher A. Caldwell reported buying additional company stock in an open-market transaction. On January 29, 2026, he purchased 1,000 shares of Concentrix common stock at a price of $37.07 per share, coded as a purchase transaction.
Following this trade, Caldwell beneficially owned 362,075 shares of Concentrix common stock, held in direct ownership. This filing reflects an increase in his personal equity stake and aligns his financial interests further with those of other shareholders.
Groupe Bruxelles Lambert and its affiliates amended their Schedule 13D on Concentrix Corporation to update ownership percentages. They report beneficial ownership of 8,773,667 shares of common stock, representing about 14.24% of Concentrix’s outstanding shares, based on 61,597,304 shares outstanding as of January 16, 2026.
The change in percentage ownership results solely from a decrease in Concentrix’s total shares outstanding. The filing also notes potential receipt of 442,759 additional earnout shares if specified share-price conditions are met and reiterates investor rights, including board nomination, lock-up, and registration rights under an existing Investor Rights Agreement.